This study identified Hemidesmus indicus as a potential source for antidiabetic medications. The herb showed high extractive yield and inhibited carbohydrate hydrolytic enzymes. Molecular modeling techniques confirmed its potential as an inhibitor of alpha-amylase and alpha-glucosidase, suggesting it could be developed as a lead for type-2 diabetes medications.